Lena Bugge Nordberg
Utdanning
- Lege (MD) ved det medisinske fakultet, Universitet i Oslo (2012)
- Doktorgrad ved det medisinske fakultet, Universitetet i Oslo (2019)
Stilling
- Post.doc. (50%) i revmatologi, Diakonhjemmet sykehus
- Lege i spesialisering (50%) indremedisin/revmatologi, Diakonhjemmet Sykehus
Interessefelt
- Inflammatoriske leddsykdommer
- Revmatoid artritt
- Ekstra-artikulære manifestasjoner ved revmatoid artritt
- Interstitiell lungesykdom ved revmatoid artritt
- Ultralyd
- Leddinjeksjoner
Annet
- I arrangørkomiteen for Grønn kongress
Prosjekter
WP1 - Behandlingsstudier
ARCTIC
Remisjon hos pasienter med revmatoid artritt: en randomisert kontrollert studie som undersøker bruk av ultralyd i klinisk oppfølging
Prosjektleder:
Espen A. HaavardsholmWP1 - Behandlingsstudier
ARCTIC FORWARD
10-års oppfølging av pasienter med revmatoid artritt som mottok strukturert behandling-til-mål-terapi i tidlig sykdomsfase.
Prosjektleder:
Siri LillegravenPublikasjoner
Publikasjoner hentet fra Nasjonalt vitenarkiv (NVA):
Agreement between patient-reported flares and clinically significant flare status in patients with rheumatoid arthritis in sustained remission: data from the ARCTIC REWIND trials
Karen Holten, Nina Paulshus Sundlisæter, Joseph Sexton, Kaja Eriksrud Kjørholt, Lena Bugge Nordberg, Tillmann Uhlig
RMD Open
2024
Cooperation across healthcare service levels for medication reviews in older people with polypharmacy admitted to a municipal in-patient acute care unit (The COOP II Study): study protocol for a randomized controlled trial
Leonor Roa Santervas, Torgeir Bruun Wyller, Eva Skovlund, Janicke Liaaen Jensen, Katrine Gahre Fjeld, Lene Hystad Hove
Trials
2024
Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-To-Target strategy
Ulf Gunnar Sundin, Nina Beate Paulshus Sundlisæter, Anna-Birgitte Aga, Joseph Sexton, Lena Kristine Bugge Nordberg, Hilde Berner Hammer
RMD Open
2021
Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial
Lena Kristine Bugge Nordberg, Siri Lillegraven, Anna-Birgitte Aga, Joseph Sexton, Inge Christoffer Olsen, Elisabeth Lie
RMD Open
2018
The impact of ultrasound on the use and efficacy of intraarticular glucocorticoid injections in early rheumatoid arthritis: Secondary analyses from a randomized trial examining the benefit of ultrasound in a clinical tight control regimen
Lena Kristine Bugge Nordberg, Siri Lillegraven, Anna-Birgitte Aga, Joseph Sexton, Elisabeth Lie, Hilde Berner Hammer
Arthritis & Rheumatology
2018
Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naïve patients classified according to the 2010 ACR/EULAR criteria
Lena Kristine Bugge Nordberg, Siri Lillegraven, Elisabeth Lie, Anna-Birgitte Aga, Inge Christoffer Olsen, Hilde Berner Hammer
Annals of the Rheumatic Diseases
2017